Secondaries announced 12.12.17

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis.

If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today!

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.

Company: Aker Biosciences, Inc.
Symbol: AKER
Price: Last Trade $0.42
Trade Date: 12/15
Shares: 13.6 million
Underwriter(s): Joseph Gunnar & Co.
Description: Akers Bio develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a time- and cost-efficient manner.
Rating = Subscription Needed

Company: Fate Therapeutics, Inc.
Symbol: FATE
Price: Last Trade $4.43
Trade Date: 12/13
Shares: 7.1 million ($30 million cash raise)
Re-Offer Range:Subscription Needed
Underwriter(s): Leerink, Piper Jaffray
Description: Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders.
Rating = Subscription Needed

Company: Helios and Matheson Analytics Inc.
Symbol: HMNY
Price: Last Trade $10.08
Trade Date: 12/13
Shares: 4.96 million ($50 million cash raise)
Re-Offer Range:Subscription Needed
Underwriter(s): Canaccord Genuity
Co-Manager(s): Maxim Group
Description: They are a provider of information technology services and solutions, offering a range of technology platforms focusing on big data, artificial intelligence, business intelligence, social listening, and consumer-centric technology.
Rating = Subscription Needed

Company: Subscription Needed
Symbol: PTI
Price: Last Trade $6.14
Trade Date: 12/14
Shares: 7 million
Underwriter(s): Leerink, RBC Capital
Co-Manager(s): H.C. Wainwright
Description: Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing.
Rating = Subscription Needed

Company: Nordic American Tankers
Symbol: NAT
Price: Last Trade $3.67
Trade Date: 12/13
Shares: 27.3 million ($100 million cash raise)
Re-Offer Range:Subscription Needed
Underwriter(s): Morgan Stanley, Clarksons Platou Securities, DNB Markets, Skandinaviska Enskilda Banken AB, Seaport Global
Description: Nordic American Tankers Limited, incorporated on June 12, 1995, is an international tanker company.
Rating = Subscription Needed

Company: Intellia Therapeutics – Block
Symbol: NTLA
Price: Last Trade $18.30
Trade Date: 12/13
Shares: 1.523 million
Re-Offer Range: Subscription Needed
Underwriter(s): UBS
Description: They are developing revolutionary genome editing therapies to cure genetic diseases with simple, targeted treatments.
Rating = Subscription Needed

Company: Noble Midstream Partners
Symbol: NBLX
Price: Last Trade $51.55
Trade Date: 12/13
Shares: 3.2 million
Re-Offer Range: Subscription Needed
Underwriter(s): Citigroup
Description: They are engaged in owning, operating, developing and acquiring a range of domestic midstream infrastructure assets.
Rating = Subscription Needed